245 results on '"NAGANO, Nobuo"'
Search Results
2. Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients
3. Association between phosphate binder pill burden and mortality risk in patients on maintenance hemodialysis: a single-center cohort study with 7-year follow-up of 513 patients
4. Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients
5. #2696 The effect of laxatives on reducing serum phosphate levels of probiotics in hemodialysis patients: a subanalysis of RCT
6. Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients
7. Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects
8. Calcimimetics for Treating Hyperparathyroidism
9. Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients
10. Magnesium and Osteoporosis
11. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
12. Impact of phosphate binders on medication dosing frequency, timing, and number of prescribed pills in hemodialysis patients
13. Klotho/FGF23 Axis in CKD
14. Cinacalcet suppresses calcification of the aorta and heart in uremic rats
15. Cinacalcet HCl Suppresses Cyclin D1 Oncogene-Derived Parathyroid Cell Proliferation in a Murine Model for Primary Hyperparathyroidism
16. The Mechanism of Decreased Serum Phosphorus Levels in Rats with Chronic Kidney Disease after Oral Administration of Bifidobacterium longum
17. Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels
18. Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
19. Acceptable number of oral pills that can be taken at one time by dialysis patients
20. SO055PROBIOTIC BIO-THREE DECREASES SERUM PHOSPHATE LEVELS WITH INVOLVEMENT OF BACTERIA IN GUT MICROBIOMA IN HEMODIALYSIS PATIENTS: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTOLLED STUDY
21. Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics
22. Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency
23. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency
24. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats
25. Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats
26. Control of parathyroid cell growth by calcimimetics
27. Monolithic ultra-broadband transimpedance amplifiers using AlGaAs/GaAs heterojunction bipolar transistors
28. Sevelamer hydrochloride (Renagel®), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency
29. Cloning of rodent megsin revealed its up-regulation in mesangioproliferative nephritis
30. Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury
31. Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism
32. Long-term observation of glomerulonephritis induced by multiple injections with anti-Thy-1 antibody in rats
33. NPS R-568 halts or reverses osteitis fibrosa in uremic rats
34. The Calcimimetic Compound NPS R-568 Suppresses Parathyroid Cell Proliferation in Rats with Renal Insufficiency: Control of Parathyroid Cell Growth Via a Calcium Receptor
35. The Mechanism of Decreased Serum Phosphorus Levels in Rats with Chronic Kidney Disease after Oral Administration of Bifidobacterium longum
36. Prescription change from cinacalcet hydrochloride to evocalcet―simultaneous switching of 147 chronic hemodialysis patients―
37. Phosphate Binders Derived from Natural Ores Contain Many Kinds of Metallic Elements Besides Their Active Ingredient Metals
38. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
39. Calcimimetics for Treating Hyperparathyroidism
40. Distribution of serum zinc levels in hemodialysis patients–factors related to hypozincemia–
41. Compliance and persistence of oral calcimimetics in maintenance hemodialysis patients: a pharmacoepidemiological study utilizing electronic health records
42. Higher reticulocyte counts are associated with higher mortality rates in hemodialysis patients: a retrospective single-center cohort study
43. Effective treatment of vascular pain during hemodialysis with auriculotherapy: a report of three cases
44. MP523CLINICAL SIGNIFICANCE OF MEDIASTINAL FAT INDEX NEWLY DEVISED IN MAINTENANCE HEMODIALYSIS PATIENTS
45. The magnesium included as a pharmaceutical excipient in phosphate binders might affect the serum magnesium levels of dialysis patients
46. The prescription of a higher number of phosphate binder pills is associated with lower medication adherence and worse serum phosphorus control
47. Impact of the Visceral Fat Area Measured by Dual Impedance Method on the Diagnostic Components of Metabolic Diseases in a Middle-aged Japanese Population
48. SP319RELATIONSHIP OF VISCERAL AND SUBCUTANEOUS FAT WITH THE DECREASE OF RENAL FUNCTION FOR SEVEN YEARS IN PEOPLE WITH OBESITY
49. SP329IMPACT OF HYPONATREMIA ON RENAL FUNCTION IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
50. Expression of the Calcium Receptor in the Primate Endocrine Pancreas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.